Director general of the Association of British Pharmaceutical Industries, Richard Barker has been at the heart of many wrangles over drug costs and availability.

While ably representing his members’ interests, he has smoothed the way for some innovative solutions and is respected in government.
With drugs second only to salaries as a component of the overall NHS bill, the relationship between the NHS and drugs companies is important; win-win solutions will be vital as health service budgets come under pressure.